Mixed Reaction to AMA's Call for Moratorium on DTC Ads

The AMA recently called for a temporary moratorium on direct-to-consumer (DTC) advertising of newly approved drugs and medical devices. See AMA Wants Halt on Drug Ads Aimed at Consumers (By Steven Reinberg, HealthDay Reporter). The reaction to the AMA's statement was mixed. The Pharmaceutical Research Manufacturers of American (PhRMA) expressed overall support for the AMA's position, but added its own program sufficiently addresses the content of DTC ads. Consumer advocacy groups, such as Commercial Alert, argue the moratorium does not go far enough and claim that DTC ads should be illegal.